Implantica AG

8IM1

Company Profile

  • Business description

    Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

  • Contact

    Aeulestrasse 45
    Vaduz9490
    LIE

    T: +423 3766066

    https://www.implantica.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    Employees

    60

Stocks News & Analysis

stocks

Goodman earnings: All eyes on data center progress

Our view after results.
stocks

Earnings winners: BHP, NAB & TLS lead the pack

The winners of this weeks earnings that saw strong investor backing
stocks

Walmart earnings: Growth in digital buoys margin amid consumer trade-down

We think Walmart stock is significantly overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,303.209.300.10%
CAC 408,515.49116.711.39%
DAX 4025,260.69217.120.87%
Dow JONES (US)49,588.98193.820.39%
FTSE 10010,686.8959.850.56%
HKSE26,413.35292.59-1.10%
NASDAQ22,875.73193.000.85%
Nikkei 22556,825.70642.13-1.12%
NZX 50 Index13,308.52135.68-1.01%
S&P 5006,905.3643.470.63%
S&P/ASX 2009,081.4017.000.19%
SSE Composite Index4,082.0751.95-1.26%

Market Movers